Ultrasound plus GCase treatment for Parkinson’s symptoms
Part of Brain & nervous system clinical trials.
This trial studies whether MR-guided focused ultrasound combined with an enzyme treatment called GCase can improve Parkinson’s disease. It includes people with specific Parkinson’s diagnosis and scan findings, and it may help those with certain genetic or imaging markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 35 and 80 years old and can give informed consent.
- You’ve had Parkinson’s disease for at least 2 years and are on stable Parkinson’s medicines for 90 days or more.
- Your Parkinson’s symptoms are mild to moderate (Hoehn and Yahr Stage 1–3) while you’re taking Parkinson’s medication.
- Your brain scan shows a dopamine deficit (a DAT SPECT scan result must be positive).
- If you join the GBA study group, you must have at least one GBA gene mutation; if not, you must have two normal (wild-type) GBA copies.
- You must be able to safely have MRI and ultrasound with contrast, and you should not have certain heart, kidney, infection, stroke/TIA, or prior brain surgery issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called DSP-1083 for people with Parkinson's disease whose symptoms are not well controlled with standard medications. The study will check if it is safe and if it helps improve movement and daily function.
This trial tests a noninvasive ultrasound treatment targeting a brain area called the pedunculopontine nucleus to help reduce freezing of gait (a sudden inability to walk) in Parkinson's disease. If you have Parkinson's and experience freezing, you may be eligible to try this new approach.
This trial studies a non-invasive procedure (MR-guided focused ultrasound) to treat Parkinson’s disease symptoms that are not well controlled by medicine. It aims to help people with significant movement problems improve their function, especially after testing how they do when medication wears off.
This trial tests whether a non-invasive ultrasound treatment, called transcranial focused ultrasound stimulation (tFUS), can improve movement and thinking in people with Parkinson's disease. It may be an option for those whose symptoms are not well controlled by medication alone.
This trial tests a non-surgical treatment that uses focused ultrasound waves to create tiny lesions in a specific part of the brain to improve Parkinson's symptoms like stiffness, slowness, and involuntary movements. It may be an option for people who have had Parkinson's for a while and have motor complications from their medications.
This trial tests a non-invasive ultrasound treatment for Parkinson's disease. It aims to see if low intensity focused ultrasound can help improve symptoms without surgery.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.